Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lowe

Showing results (241-250 of 591) with videos related to

Pageof 60
Sort By:
Cancer Cell|June 28, 2002
Dissecting p53 tumor suppressor functions in vivoClemens A Schmitt, Jordan S Fridman, Meng Yang, et al.
Cold Spring Harbor Symposia on Quantitative Biology|May 23, 2003
DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma modelC A Schmitt, R R Wallace-Brodeur, C T Rosenthal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2019
Preclinical murine platform to evaluate therapeutic countermeasures against radiation-induced gastrointestinal syndromePaul B Romesser, Amanda S Kim, Jeho Jeong, et al.
Journal of Lipid Research|November 1, 1988
Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactionsD L Ebert, N Maeda, S W Lowe, et al.
Genes & Development|October 29, 1999
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53C A Schmitt, M E McCurrach, E de Stanchina, et al.
Biomacromolecules|October 29, 2010
Effects of polymer molecular weight on the size, activity, and stability of PEG-functionalized trypsinKaren Chiu, Lauren L Agoubi, Iris Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic targetAnna Saborowski, Michael Saborowski, Monika A Davare, et al.
Genes & Development|October 9, 1998
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalingA W Lin, M Barradas, J C Stone, et al.
The EMBO Journal|August 13, 2003
Reversal of human cellular senescence: roles of the p53 and p16 pathwaysChristian M Beauséjour, Ana Krtolica, Francesco Galimi, et al.
Archives of Biochemistry and Biophysics|December 15, 2010
N-acylethanolamines as novel alcohol dehydrogenase 3 substratesMilena Ivkovic, Daniel R Dempsey, Sumit Handa, et al.
Pageof 60

Showing results (241-250 of 591) with videos related to

Sort By:
Pageof 60
Cancer Cell|June 28, 2002
Dissecting p53 tumor suppressor functions in vivoClemens A Schmitt, Jordan S Fridman, Meng Yang, et al.
Cold Spring Harbor Symposia on Quantitative Biology|May 23, 2003
DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma modelC A Schmitt, R R Wallace-Brodeur, C T Rosenthal, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2019
Preclinical murine platform to evaluate therapeutic countermeasures against radiation-induced gastrointestinal syndromePaul B Romesser, Amanda S Kim, Jeho Jeong, et al.
Journal of Lipid Research|November 1, 1988
Primary structure comparison of the proposed low density lipoprotein (LDL) receptor binding domain of human and pig apolipoprotein B: implications for LDL-receptor interactionsD L Ebert, N Maeda, S W Lowe, et al.
Genes & Development|October 29, 1999
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53C A Schmitt, M E McCurrach, E de Stanchina, et al.
Biomacromolecules|October 29, 2010
Effects of polymer molecular weight on the size, activity, and stability of PEG-functionalized trypsinKaren Chiu, Lauren L Agoubi, Iris Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic targetAnna Saborowski, Michael Saborowski, Monika A Davare, et al.
Genes & Development|October 9, 1998
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalingA W Lin, M Barradas, J C Stone, et al.
The EMBO Journal|August 13, 2003
Reversal of human cellular senescence: roles of the p53 and p16 pathwaysChristian M Beauséjour, Ana Krtolica, Francesco Galimi, et al.
Archives of Biochemistry and Biophysics|December 15, 2010
N-acylethanolamines as novel alcohol dehydrogenase 3 substratesMilena Ivkovic, Daniel R Dempsey, Sumit Handa, et al.
Pageof 60